129 related articles for article (PubMed ID: 38083989)
1. Combined untargeted and targeted lipidomics approaches reveal potential biomarkers in type 2 diabetes mellitus cynomolgus monkeys.
Tian CY; Yang QH; Lv HZ; Yue F; Zhou FF
J Med Primatol; 2024 Feb; 53(1):e12688. PubMed ID: 38083989
[TBL] [Abstract][Full Text] [Related]
2. Preliminary serum and fecal metabolomics study of spontaneously diabetic cynomolgus monkeys based on LC-MS/MS.
Tian C; Qiu M; Lv H; Yue F; Zhou F
J Med Primatol; 2022 Dec; 51(6):355-366. PubMed ID: 35993379
[TBL] [Abstract][Full Text] [Related]
3. Serum lipidomics profiles reveal potential lipid markers for prediabetes and type 2 diabetes in patients from multiple communities.
Xuan Q; Hu C; Zhang Y; Wang Q; Zhao X; Liu X; Wang C; Jia W; Xu G
Front Endocrinol (Lausanne); 2022; 13():966823. PubMed ID: 36060983
[TBL] [Abstract][Full Text] [Related]
4. Comparative plasma lipidome between human and cynomolgus monkey: are plasma polar lipids good biomarkers for diabetic monkeys?
Shui G; Stebbins JW; Lam BD; Cheong WF; Lam SM; Gregoire F; Kusonoki J; Wenk MR
PLoS One; 2011 May; 6(5):e19731. PubMed ID: 21573191
[TBL] [Abstract][Full Text] [Related]
5. Lipidomic analysis of serum exosomes identifies a novel diagnostic marker for type 2 diabetes mellitus.
Zhang L; Lu T; Zhou B; Sun Y; Wang L; Qiao G; Yang T
Lab Med; 2024 May; ():. PubMed ID: 38809765
[TBL] [Abstract][Full Text] [Related]
6. LC-MS-Based Lipidomic Analysis of Serum Samples from Patients with Type 2 Diabetes Mellitus (T2DM).
Liu J; Bai L; Wang W; Song Y; Zhao W; Li Q; Wu Q
Dis Markers; 2022; 2022():5559470. PubMed ID: 35190756
[TBL] [Abstract][Full Text] [Related]
7. Lipidomics based on UHPLC/Q-TOF-MS to characterize lipid metabolic profiling in patients with newly diagnosed type 2 diabetes mellitus with dyslipidemia.
Zhong X; Xiao C; Wang R; Deng Y; Du T; Li W; Zhong Y; Tan Y
Heliyon; 2024 Feb; 10(4):e26326. PubMed ID: 38404868
[TBL] [Abstract][Full Text] [Related]
8. Integrated lipids biomarker of the prediabetes and type 2 diabetes mellitus Chinese patients.
Yang J; Wang M; Yang D; Yan H; Wang Z; Yan D; Guo N
Front Endocrinol (Lausanne); 2022; 13():1065665. PubMed ID: 36743922
[TBL] [Abstract][Full Text] [Related]
9. Age Related Prevalence of Mild Cognitive Impairment in Type 2 Diabetes Mellitus Patients in the Indian Population and Association of Serum Lipids With Cognitive Dysfunction.
Chakraborty A; Hegde S; Praharaj SK; Prabhu K; Patole C; Shetty AK; Mayya SS; Acharya RV; Hande HM; Prabhu MM; Upadhya D
Front Endocrinol (Lausanne); 2021; 12():798652. PubMed ID: 35035379
[TBL] [Abstract][Full Text] [Related]
10. Discovery of lipid profiles of type 2 diabetes associated with hyperlipidemia using untargeted UPLC Q-TOF/MS-based lipidomics approach.
Yan L; Han P; Man J; Tian Y; Wang F; Wang J
Clin Chim Acta; 2021 Sep; 520():53-62. PubMed ID: 34077755
[TBL] [Abstract][Full Text] [Related]
11. High-Coverage Targeted Lipidomics Reveals Novel Serum Lipid Predictors and Lipid Pathway Dysregulation Antecedent to Type 2 Diabetes Onset in Normoglycemic Chinese Adults.
Lu J; Lam SM; Wan Q; Shi L; Huo Y; Chen L; Tang X; Li B; Wu X; Peng K; Li M; Wang S; Xu Y; Xu M; Bi Y; Ning G; Shui G; Wang W
Diabetes Care; 2019 Nov; 42(11):2117-2126. PubMed ID: 31455687
[TBL] [Abstract][Full Text] [Related]
12. RNA-seq analysis of the transcriptome of the liver of cynomolgus monkeys with type 2 diabetes.
Li X; Lin Z; Zhan X; Gao J; Sun L; Cao Y; Qiu H
Gene; 2018 Apr; 651():118-125. PubMed ID: 29414690
[TBL] [Abstract][Full Text] [Related]
13. Lipidomics of the erythrocyte membrane and network pharmacology to explore the mechanism of mangiferin from Anemarrhenae rhizoma in treating type 2 diabetes mellitus rats.
Zhong Y; Xu Y; Tan Y; Zhang X; Wang R; Chen D; Wang Z; Zhong X
J Pharm Biomed Anal; 2023 Jun; 230():115386. PubMed ID: 37044004
[TBL] [Abstract][Full Text] [Related]
14. Lipidomics Reveals Serum Specific Lipid Alterations in Diabetic Nephropathy.
Xu T; Xu X; Zhang L; Zhang K; Wei Q; Zhu L; Yu Y; Xiao L; Lin L; Qian W; Wang J; Ke M; An X; Liu S
Front Endocrinol (Lausanne); 2021; 12():781417. PubMed ID: 34956093
[TBL] [Abstract][Full Text] [Related]
15. The Changes of Lipidomic Profiles Reveal Therapeutic Effects of Exenatide in Patients With Type 2 Diabetes.
Zhang L; Hu Y; An Y; Wang Q; Liu J; Wang G
Front Endocrinol (Lausanne); 2022; 13():677202. PubMed ID: 35432194
[TBL] [Abstract][Full Text] [Related]
16. LC-MS-Based Untargeted Metabolomics Reveals Early Biomarkers in STZ-Induced Diabetic Rats With Cognitive Impairment.
Chen R; Zeng Y; Xiao W; Zhang L; Shu Y
Front Endocrinol (Lausanne); 2021; 12():665309. PubMed ID: 34276557
[TBL] [Abstract][Full Text] [Related]
17. Lipidome as a predictive tool in progression to type 2 diabetes in Finnish men.
Suvitaival T; Bondia-Pons I; Yetukuri L; Pöhö P; Nolan JJ; Hyötyläinen T; Kuusisto J; Orešič M
Metabolism; 2018 Jan; 78():1-12. PubMed ID: 28941595
[TBL] [Abstract][Full Text] [Related]
18. Lipidomics characterization of the mechanism of Cynomorium songaricum polysaccharide on treating type 2 diabetes.
Shi ZQ; Wang LY; Zheng JY; Xin GZ; Chen L
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1176():122737. PubMed ID: 34052560
[TBL] [Abstract][Full Text] [Related]
19. LC-MS-Based Metabolomics and Lipidomics Study of High-Density-Lipoprotein-Modulated Glucose Metabolism with an apoA-I Knockout Mouse Model.
Liu J; Zhao M; Zhu Y; Wang X; Zheng L; Yin Y
J Proteome Res; 2019 Jan; 18(1):48-56. PubMed ID: 30543107
[TBL] [Abstract][Full Text] [Related]
20. Evaluating a targeted multiple reaction monitoring approach to global untargeted lipidomic analyses of human plasma.
Khan MJ; Codreanu SG; Goyal S; Wages PA; Gorti SKK; Pearson MJ; Uribe I; Sherrod SD; McLean JA; Porter NA; Robinson RAS
Rapid Commun Mass Spectrom; 2020 Nov; 34(22):e8911. PubMed ID: 32738001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
